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ABSTRACT 
 
Objective: To examine the relationship between sleep duration and mortality and to quantify 
the likely impact of residual confounding due to poor health status on any observed 
association. 
Methods: The sample included 227,815 Australian adults aged 45 years and older recruited 
from 2006–2009 (the 45 and Up Study). Sleep duration and relevant covariates (e.g., health 
status, demographic factors) were assessed through a self-report questionnaire. These data 
were linked with mortality data from the New South Wales Registry of Births, Deaths, and 
Marriages up to December 2010 (mean follow-up period, 2.8 y). Cox proportional hazards 
models examined the relationship between sleep duration and all-cause mortality adjusting 
for relevant sociodemographic covariates (e.g., age, gender, marital status), with further 
stratification by baseline health status based on physical functioning and preexisting disease. 
Results: The adjusted mortality risk was significantly higher in individuals reporting 
<6 hours of sleep (hazard ratio [HR], 1.13[1.01–1.25]) and ≥ 10 hours of sleep (HR, 
1.26[1.16–1.36]), compared to those reporting 7 hours of sleep per night. These associations 
differed by baseline health status (p[interaction] = 0.026) such that there was no significant 
relationship of sleep duration to mortality in those with good health at baseline. 
Conclusion: Following careful prospective controlling for baseline health, mortality risk 
does not significantly vary according to sleep duration. Previous findings suggesting a 
relationship between sleep duration and mortality could be affected by residual confounding 
by poor preexisting health, as reflected by a combination of preexisting illnesses and 
functional limitations. 
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INTRODUCTION 
 
A growing body of research indicates a U-shaped association between sleep duration 
and mortality risk.  In particular large-scale epidemiological studies indicate that individuals 
who report short (e.g., ≤ 6 hours a night) and long sleep (e.g., ≥ 9 hours a night) durations 
have elevated odds of mortality relative to those sleeping 7 – 8 hours a night [1-12].  A 
number of mechanisms have been proposed to explain this relationship.  For instance, it has 
been suggested that short sleep could contribute to mortality via chronic health conditions 
(e.g., heart disease and diabetes) and/or by increasing the likelihood of accidents because of 
impaired cognitive functioning.   
Despite causal mechanisms that have been proposed linking long sleep to mortality, a 
number of studies have suggested that this association likely reflects residual confounding 
with underlying poor health [13], and the relationship of short sleep to mortality may be 
similarly affected. However, detailed empirical data on this are limited. Hence, rather than 
sleep duration independently contributing to mortality risk, it is possible that individuals with 
preexisting health conditions experience disturbed sleep patterns with these preexisting 
conditions themselves contributing to greater mortality [1] and [14]. Preexisting health 
conditions have been shown to underlie the relationships between sleep disturbances and 
other health outcomes. For instance, Cairns et al. [15] found that the apparent association 
between daytime napping and subsequent cancer risk was the result of underlying disease, 
rather than napping itself contributing to cancer risk.  
Few studies have examined the impact of preexisting health conditions on the association 
between sleep and mortality, and those that are available have produced mixed results. Patel 
et al. [7], Suzuki et al. [10], and Kakizaki et al. [16] found that short sleep was linked with 
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elevated mortality in both healthy and less healthy individuals. In contrast, using a wider 
variety of health-related measures, Mesas et al. [1] only observed the association between 
short sleep and mortality in those with poorer cognitive function. The findings for long sleep 
have been more consistent, with long sleep generally associated with mortality risk regardless 
of health status [1], [7], [8], [10] and [16]. However, Kakizaki et al. [16] did find that the 
relationship between long sleep and stroke mortality was higher in those with poorer health, 
as reflected by self-rated health and physical function. 
In our paper, we aimed to prospectively investigate the relationship between sleep duration 
and mortality. This investigation involved examining the extent to which any observed 
variation in these relationships could be explained by baseline health status. We assessed 
health status in relation to preexisting health conditions (e.g., cancer, heart disease) and 
physical functional limitation; in combination, these factors provide a more comprehensive 
measure of baseline health compared to some previous studies, and they allow for an 
examination of the severity of poor health. We hypothesized, a priori, that if sleep duration 
were to independently and causally influence mortality as suggested by previous research, 
then an association between sleep duration and mortality would be evident in individuals who 
were healthy and less healthy at baseline, provided appropriate statistical power is present. If 
this association is absent in individuals in adequate health at baseline and is only present in 
individuals with preexisting disease or functional limitation, this finding would suggest that 
that there is residual confounding with poor baseline health in the association between sleep 
duration and mortality risk. 
METHODS 
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Our paper utilized data collected through the 45 and Up Study, a large cohort study of 
267,153 adults ages 45 years and older who resided in the state of New South Wales in 
Australia. The primary objective of the 45 and Up Study is to collect information from a large 
heterogeneous sample of adults to investigate healthy aging [17]. Participants for this study 
were recruited through the Medicare Australia enrollment database, which is the publicly 
funded health insurance system in Australia and includes virtually all Australian residents. 
Potential participants were mailed a self-report questionnaire assessing a variety of 
sociodemographic and health-related factors; the response rate was approximately 18%. 
Informed consent was obtained from all participants and the 45 and Up Study received ethics 
approval from the University of New South Wales Human Research Ethics Committee. 
Ethics approval to use the 45 and Up Study data in our paper was obtained from the New 
South Wales Population and Health Services Ethics Committee. 
Measures 
Data on all variables assessed in this study besides the index of remoteness and 
mortality were derived the baseline 45 and Up Study questionnaire. The self-report 
questionnaire asked the following question on sleep duration, “About how many hours in 
each 24-hour day do you usually spend sleeping (including at night and naps)?” Sleep 
duration was reported on a continuous scale and then divided into 6 categories: < 6 hours 
sleep, 6 hours sleep (i.e., ≥ 6 hours and < 7 hours), 7 hours (i .e., ≥ 7 hours and < 8 hours), 8 
hours (i.e., ≥ 8 hours and < 9 hours), 9 hours (i.e., ≥ 9 hours and < 10 hours), and  ≥ 10 hours 
[9].  The reference category was defined, a priori, as 7 hours in a 24-hour period, which is 
consistent with previous research [9]. Data on all-cause mortality between February 1, 2006 
and December 31, 2010 were available from the New South Wales Registry of Births, Deaths 
and Marriages and were linked through the Centre for Health Record Linkage (CHeReL: 
NSW, Australia). The mean period of follow-up was 2.8 years. 
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Health status was determined on the basis of preexisting illness at baseline and 
functional capacity. The presence of preexisting illness was based on self-reported doctor 
diagnosis of diabetes mellitus, heart disease, or stroke, as well as melanoma, breast cancer (in 
women), prostate cancer (in men), and other cancers. These conditions were chosen to be as 
consistent as possible with the Charlson comorbidity index scale [18] using the available 
data. There were complete data for all comorbid preexisting illnesses (e.g., diabetes mellitus, 
heart disease, stroke, melanoma, breast cancer [in women], prostate cancer [in men], other 
cancers), but we excluded a small number of individuals who had undergone treatment for 
cancer in the month prior to the survey (n = 6708). 
Functional capacity was assessed using the 10-item physical functioning subscale of 
the Medical Outcomes Study; this subscale is equivalent to the physical functioning subscale 
of the short-form health survey 36 [19]. Higher scores on this scale indicate fewer functional 
limitations. On the basis of preexisting illness and functional capacity we created 2 groups: 
(1) healthy, whereby individuals had no reported disease at baseline and a physical 
functioning score of 75 to 100 and (2) less healthy, defined as having one or more chronic 
conditions at baseline or a physical functioning score of less than 75. There were some 
missing data on responses to the physical functioning items; for participants with less than 
50% of missing data on these items, imputation based on the mean of other values was used 
[20]. However, when more than 50% of items were missing, the Medical Outcomes Study 
physical functioning scale variable was treated as missing (N = 21,364); for these individuals 
health status was assigned by preexisting serious illness. We note that this did not bias the 
reported results, as a sensitivity analysis that excluded these 21,364 individuals produced 
highly concordant results as those reported with unchanged conclusions. 
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A number of covariates were included in the analyses. These included gender, age 
(divided into 5-year age groups), education level (no school certificate or other qualification, 
school of intermediate certificate, higher school or leaving certificate, 
trade/diploma/certificate, and University degree or higher), and marital status (single, 
widowed, divorced or separated, married or de facto relationship). In addition, participants 
were asked about their health insurance status (no private health insurance, private health 
insurance, or Department of Veterans’ Affairs card), and their yearly household income (in 
Australian dollars) before tax (< $10 000, $10 000-$29 999, $30 000-$69 999, > $70 000, 
with “I would rather not answer the question” as a further response category).  Information on 
weekly alcohol consumption (0 drinks, 1 – 7 drinks, 8 – 14 drinks, ≥ 15 drinks),  physical 
activity (≤ 30 min/d, > 30 min/d), and smoking status (current smoker, former smoker, never 
smoker) were also collected, as were self-reported height and weight which were used to 
calculate body mass index (≤18.5 kg/m2, 18.5 -<25.0 kg/m2, 25.0-29.9 kg/m2, ≥30.0 kg/m2).    
Participant postcodes derived from the Medicare Australia enrollment database were 
used to assess remoteness (i.e., if individuals lived in a major city, rural, or remote area). This 
process was achieved using the Accessibility/Remoteness Index of Australia (ARIA) [21], in 
which participants were categorized as living in a major city (ARIA, 0–0.2), an inner regional 
area (ARIA > 0.2 and ≤ 2.4), an outer regional area (ARIA > 2.4 and ≤ 5.92), or a 
remote/very remote area (ARIA > 5.92).  Participants with missing data for sleep duration, 
age, or gender (n=7426) were excluded from the analyses.  For the remaining variables, an 
additional category was created to code missing data where appropriate. 
Statistical Analysis 
 The association between sleep duration and all-cause mortality was examined using 
Cox proportional hazards models, with time to death from date of baseline questionnaire 
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specified as the outcome. Individuals surviving the follow-up period were treated as censored 
observations. All models satisfied the Cox proportional hazards model assumption. The 
analyses were performed using Stata version 11.1, with the relative risk for death estimated 
for each sleep category relative to the reference category expressed as a hazard ratio (HR), 
with 95% confidence intervals (CI). The analyses involved testing an initial model, in which 
we examined the relationship between sleep duration and mortality, controlling for age and 
gender. A second model was then tested whereby we entered additional covariates into the 
analysis. For parsimony, covariates that did not explain variation in all-cause mortality at 
p < 0.05 were removed from the final multivariate model. 
We examined the main association between sleep duration and mortality separately for 
individuals defined as healthy and less healthy. An interaction term examining if the 
relationship between sleep duration and mortality varied according to health status was then 
added to the model. This interaction term was formed as a multiplicative combination of the 
categorical sleep duration predictor with 6 categories (one of which [7 h] was the reference 
category) and the binary health status covariate with 2 categories (one of which [healthy] was 
the reference category). The significance of the interaction term was examined using a 
likelihood ratio test, which compared the model with and without the interaction terms. 
Investigation of a significant interaction effect was separately performed for the healthy and 
less healthy groups. Statistical significance was determined by a p value of <0.05. 
 
RESULTS 
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 Linked data were available for 241,949 adults; however, the final sample consisted of 
227,815 participants (53.7% women, 46.3% men) aged 45 years and older at baseline when 
cases with missing data (e.g., sleep duration, age, gender) were excluded. Most participants 
were aged 45 to 64 years at baseline (60.7%). Consistent with cohorts from other countries, 
the majority of our sample reported sleep durations of 7 hours (23.9%) or 8 hours (40.7%) a 
night. As shown in Table 1, 15.8% reported short sleep (i.e., ≤6 hours a night) with 19.6% 
reporting long sleep duration (i.e., ≥9 hours).  Females and individuals aged ≥80 years were 
significantly more likely to report short sleep, whereas long sleep was more likely to be 
reported by males and those aged ≥80 years.  Baseline health status was also significantly 
associated with sleep duration.  In particular, there was evidence of a U-shaped association 
between pre-existing illness and sleep duration, as well as between physical functioning and 
sleep duration.   
Table 1. The relationship between sleep duration and key study variables. 
 
<6 h 
(n = 8308; 
3.6%) 
6 h 
(n = 27,797; 
12.2%) 
7 h 
(n = 54,336; 
23.9%) 
8 h 
(n = 97,791; 
40.7%) 
9 h 
(n = 27,111; 
11.9%) 
P 10 h 
(n = 17,472; 
7.7%) 
p Value 
Gender       <0.001 
Women 4905 (4.0%) 15,223 (12.5%) 
28,626 
(23.4%) 
50,821 
(41.6%) 
14,392 
(11.8%) 8170 (6.7%)  
Men 3403 (3.2%) 12,574 (11.9%) 
25,710 
(24.3%) 
41,970 
(39.7%) 
12,719 
(12.0%) 9302 (8.8%)  
Age       <0.001 
45–64 y 4426 (3.2%) 17,852 (12.8%) 
37,936 
(27.2%) 
58,751 
(42.1%) 
13,943 
(10.0%) 6650 (4.8%)  
65–79 y 2538 (3.9%) 7359 (11.3%) 12,863 (19.7%) 
26,182 
(40.1%) 9639 (14.8%) 6637 (10.2%)  
P 80 y 1344 (5.8%) 2586 (11.2%) 3537 (15.4%) 7858 (34.1%) 3529 (15.3%) 4185 (18.2%)  
Preexisting 
illnesses        
None 5855 (3.3%) 21,460 (12.2%) 
44,188 
(25.2%) 
72,945 
(41.6%) 
19,952 
(11.4%) 10,806 (6.2%) <0.001 
P 1 2453 (4.7%) 6337 (12.0%) 10,148 (19.3%) 
19,846 
(37.7%) 7159 (13.6%) 6666 (12.7%)  
MOS-PF       <0.001 
<75 2873 (6.4%) 5832 (13.0%) 7371 (16.4%) 15,117 (33.7%) 6144 (13.7%) 7570 (16.9%)  
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<6 h 
(n = 8308; 
3.6%) 
6 h 
(n = 27,797; 
12.2%) 
7 h 
(n = 54,336; 
23.9%) 
8 h 
(n = 97,791; 
40.7%) 
9 h 
(n = 27,111; 
11.9%) 
P 10 h 
(n = 17,472; 
7.7%) 
p Value 
75–100 5435 (3.0%) 21,965 (12.0%) 
46,965 
(25.7%) 
77,674 
(42.5%) 
20,967 
(11.5%) 9902 (5.4%)  
Abbreviations: h, hour; y, year; MOS-PF, Medical Outcomes Study-Physical 
Functioning Scale. 
 
Over the 5-year period, there was a total of 8782 deaths from all causes. After 
adjusting for age and gender, the risk for mortality during the follow-up period was 
significantly higher in individuals reporting short or long sleep duration compared to those 
reporting 7 hours of sleep per night (Table 2; hazard ratios [HRs]) (95% CI, 1.27[1.14–1.41] 
for ≤6 hours and 1.43[1.32-1.54] for ≥10 hours ).  These associations were attenuated with 
additional adjustment for age, gender, marital status, private health insurance, smoking status, 
alcohol consumption, body mass index, physical activity, and baseline health status. 
However, in the total sample short sleep (HR, 1.13[1.01–1.25]) and long sleep duration (HR, 
1.26[1.16–1.36]) remained significantly associated with mortality risk compared to 7 hours of 
sleep.   
Table 2. The relationship between sleep duration and mortality risk in the total sample. Data 
are presented as hazard ratios (with 95% confidence intervals) adjusted for covariates. 
 
N IY Events 
Adjusted for age and gender 
 
Fully adjusted resultsa 
 
HR 95% CI HR 95% CI 
<6 h 8308 23,616 429 1.27* 1.14–1.41 1.13* 1.01–1.25 
6 h 27,796 78,756 1016 1.03 0.96–1.11 0.99 0.91–1.06 
7 h 54,335 153,205 1803 Referent 
 
Referent 
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N IY Events 
Adjusted for age and gender 
 
Fully adjusted resultsa 
 
HR 95% CI HR 95% CI 
8 h 92,789 258,233 3302 1.03 0.97–1.09 1.02 0.96–1.08 
9 h 27,111 74,394 1088 1.05 0.97–1.13 1.04 0.96–1.12 
P10 h 17,471 47,184 1144 1.43* 1.32–1.54 1.26* 1.16–1.36 
Abbreviations: CI, confidence interval; h, hour; HR, hazard ratio; IY, individual-years; N, number of 
participants. 
* p < 0.05. 
a HR adjusted for age, gender, marital status, private health insurance, smoking status, alcohol 
consumption, body mass index, sufficient physical activity, and baseline health status. 
 
When these relationships were separately examined in those classified as healthy at baseline, 
the association was attenuated such that there was no significant relationship of sleep 
duration to mortality (corresponding HRs, 1.09[0.89–1.32] and 1.03[0.88–1.20], respectively) 
(Fig. 1; Table 3). In contrast, a U-shaped relationship between sleep duration and mortality 
was observed in the less healthy group. The sleep duration by health status interaction was 
significant (for interaction, 12.69; p = 0.026), indicating that the relationship between sleep 
duration and mortality varied by baseline health status. 
Figure 1.  Mortality risk associated with each of the sleep categories for individuals in the 
healthy (A) and less healthy groups (B).  Data are presented as hazard ratios (with 95% 
confidence intervals) adjusted for covariates.  Although the hazard curves are separately 
shown in the figure, they were estimated from a single model based on the main effects for - 
and an interaction term between - health status and sleep duration. 
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DISCUSSION 
In the present sample, and without comprehensive consideration of baseline health 
status, both short (< 6 hours) and long ( ≥ 10 hours) sleep were significantly associated with 
all-cause mortality, independent of a range of sociodemographic and behavioral factors. This 
finding is consistent with existing studies conducted in countries such as the United States, 
the United Kingdom, Finland, and Singapore [7], [8], [11] and [12]. However, further 
investigation indicated that the nature of this association significantly varied based on health 
status, which was assessed in relation to preexisting illness (e.g., cancer, heart disease) and 
functional limitation (determined using the Medical Outcomes Study Physical Functioning 
scale). In particular we found that short and long sleep duration were not associated with 
elevated mortality when data were restricted to individuals who were healthy at baseline. This 
group is least likely to have findings affected by residual confounding or reverse causality. 
Table 3. Hazard ratios showing the association of sleep duration with mortality risk from a 
model including an interaction term between sleep duration and health status. 
 
N IY Events HR 95% CI 
Healthy group a 
<6 h 3252 9315 113 1.09 0.89–1.32 
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N IY Events HR 95% CI 
6 h 15,585 44,521 432 0.92 0.83–1.04 
7 h 35,884 101,451 1018 Referent – 
8 h 56,951 158,751 1564 0.97 0.89–1.05 
9 h 14,597 40,040 408 0.94 0.83–1.05 
P 10 h 5724 15,506 201 1.03 0.88–1.20 
 Less healthy groupb 
<6 h 5056 14,301 316 1.20* 1.05–1.38 
6 h 12,211 34,230 584 1.07 0.96–1.19 
7 h 18,451 51,751 785 Referent 
 
8 h 35,839 99,478 1738 1.10* 1.01–1.20 
9 h 12,514 34,354 680 1.14* 1.03–1.27 
P 10 h 11,747 31,675 943 1.38* 1.25–1.52 
Abbreviations: CI, confidence interval; h, hour; HR, hazard ratio; IY, individual-years; N, 
number of participants. 
* p < 0.05. 
a Group characterized by absence of cancer, heart disease, diabetes mellitus, and stroke, and 
method of scoring physical functioning (MOS-PF) score ⩾75. 
b  Group characterized by the presence of one or more chronic conditions at baseline and a MOS-PF 
<75. 
 
This finding is important, as a variety of mechanisms have been proposed to explain 
the relationship between sleep duration and mortality. It has been suggested, for example, that 
shorter sleep durations contribute to elevated mortality risk via pathways such as an increased 
risk for chronic health conditions including heart disease, diabetes mellitus, and obesity, 
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which have been linked with shorter sleep durations and overall mortality. Grandner and 
Drummond [13] also proposed that factors such as changes in cytokine levels and a reduced 
photoperiod (i.e., the rate of daylight to darkness) may contribute to elevated mortality in 
long sleepers. 
Our results provide some evidence against these causal mechanisms and suggest that 
the relationship between sleep duration and mortality is due to residual confounding with 
poor health at baseline. This conclusion is based on the proposition that if sleep duration were 
genuinely causally related to mortality, then an association would be observed regardless of 
health status. Using data on the presence of specific chronic health conditions and functional 
limitations due to poor physical health or disability we were able to, a priori, define a group 
that was less likely to have substantial variations in sleep durations due to preexisting poor 
health. Because we did not observe an association between sleep duration and mortality in 
this specific group despite reasonable power, it suggests that residual confounding may 
underlie the relationship between sleep duration and mortality observed in the total sample. 
Our findings are novel, as few studies have previously investigated if the association 
between sleep duration and mortality varies according to health status. Available studies 
indicate that short and long sleep generally are associated with mortality risk regardless of 
health status [1], [7], [8] and [10]. The exception has been shown in the study by Mesas et al. 
[1], who observed that the relationship between short sleep duration and mortality was only 
evident in individuals with poorer cognitive functioning. However, research investigating the 
relationship between insomnia and mortality risk also has indicated that this association is 
only evident in those with preexisting health conditions [22]. It is important to note that the 
assessment of health status has been relatively limited in previous studies examining sleep 
duration and mortality, with the focus primarily on preexisting disease. This is a limitation, as 
it is likely that sleep duration varies not only according to whether or not someone has a 
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specific illness (e.g., ischemic heart disease) but also according to the severity of the disease. 
This information is not appropriately captured by adjustment for binary variables reflecting 
health status (e.g., presence vs absence of a health condition). As a result, residual 
confounding may not have been effectively addressed in previous studies. Our research is 
better able to address this, as we assessed health status in relation to preexisting illness and 
functional limitations, which are more indicative of an individual’s overall health. Therefore, 
our results provided supportive evidence that the nature of the association varies by health 
status and that residual confounding may well account for previous associations between 
sleep duration and mortality. 
It is important to acknowledge that there are several ways to assess residual 
confounding. In addition to the approach adopted in our paper, another method involves 
investigating if the relationship between sleep duration and mortality changes with increasing 
duration of follow-up. If, for example, the magnitude of the relationship diminishes over 
time, then it suggests that the association is due to residual confounding with another factor at 
baseline. We were unable to perform these analyses in our study given that our analyses were 
limited to a relatively short period of follow-up. However, Cairns et al. [15] recently adopted 
this approach to investigate the relationship between daytime napping and the risk for cancer. 
Their results demonstrated that the magnitude of this relationship significantly weakened 
over time such that daytime napping was not associated with breast cancer and only 
marginally associated with other cancers 4 or more years after baseline. This finding suggests 
that the relationship between daytime napping and cancer risk also could be from preexisting 
disease. Therefore, although residual confounding can be difficult to investigate, it is 
something that needs to be carefully examined in the context of sleep duration and outcomes 
such as mortality. Two possible ways of investigating residual confounding in the present 
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context are to investigate the effects of preexisting health concerns and the effects of 
increased duration of follow-up. 
Despite the novelty of the findings, there are several limitations of our study. Many 
large cohort studies use a single item to asses sleep duration, but this is potentially 
problematic as it may lead to inaccurate estimates of sleep duration and be biased by factors 
such as age. For example, self-reported sleep duration moderately correlates with actigraph-
measured sleep but may overestimate sleep duration by up to 52 minutes a night [23]. 
Although this is a limitation of this study, the overestimation of sleep duration may bias the 
results towards the null. This hypothesis is supported by research showing that the magnitude 
of the U-shaped association between sleep duration and mortality is less pronounced when 
using subjective vs objective measures of sleep duration [23]. 
A further consideration is that sleep duration is just one dimension of sleep and does 
not provide an indication of sleep disturbances, which also may be important in 
understanding how sleep is related to mortality [24]. Future research should therefore assess 
other dimensions of sleep, such as sleep quality and sleep disturbances in addition to sleep 
duration. Our study included a range of factors that could potentially confound the 
association between sleep duration and mortality in addition to preexisting health. However, 
other factors such as obstructive sleep apnea and depression may also confound these 
relationships but were not included in our paper. Therefore, it is possible that the associations 
observed in the less healthy groups are the result of residual confounding due to these other 
factors. Future research may benefit from addressing these other variables as potential 
confounders to further clarify the nature of the relationship between sleep duration and 
mortality. 
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The period of follow-up in our study was relatively short, which can be a concern, as 
sleep is estimated to be relatively close to the event and also because the potential effects of 
sleep on mortality may take a longer period of time to occur. As noted above, longer periods 
of follow-up also could be beneficial in further investigating residual confounding. 
A final limitation of our study relates to the response rate of 18%. Although this 
response rate is consistent with many contemporary cohort studies, it does raise the 
possibility of biases due to a lack of representativeness. In general, the 45 and Up Study is 
underrepresented by men, younger individuals, and those living in major cities [25]. In 
addition, the sample is wealthier and healthier (reflected by lower smoking rates and higher 
self-rated health) compared to the general population [25]. Empirical data from the 45 and Up 
Study support the general epidemiologic axiom that relative risks based on internal 
comparisons within the cohort are unlikely to be biased by lack of representativeness; 
however, the possibility of bias cannot be entirely excluded [25] and [26]. 
Conclusions 
Despite these limitations, our study also has a lot of strengths including the use of 
longitudinal data from a large sample size. In addition, we were able to control for a large number of 
covariates (e.g., sociodemographic factors, health behaviors), which could have confounded the 
relationship between sleep duration and mortality. The utilization of a multidimensional measure to 
assess health, which combined preexisting health conditions with functional limitations to assess 
health status, also is a key strength of our study. This is because the combined measure incorporated 
both the presence and severity of a preexisting illness or health condition, and hence enabled us to 
better examine if residual confounding explained the relationship between sleep duration and 
mortality. This component is important, as sleep duration is increasingly discussed as a potential risk 
factor for mortality, but our results indicate that the nature of the relationship varies according to 
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health status and is not evident in individuals without health concerns and functional limitations at 
baseline. In combination with the known relationships of sleep disturbance to baseline health, the 
null findings of the sleep duration mortality in healthier individuals in our study suggest that the 
observed relationship of short and long sleep duration to mortality may well be a result of the 
preexisting disease. 
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